Clinical Trial

Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The overall purpose of this randomized control trial (RCT) is to determine the clinical effect of a multilevel, RPM-enhanced intervention during and after completion of outpatient CAR-T therapy in 190 patients and their family caregivers (FCGs).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-09-12; most recent amendment 2026-01-27.
Status change: Not Yet Recruiting → Recruiting 2025-09-29
Trial Details
NCT Number NCT07186192
Lead Sponsor City of Hope Medical Center
Collaborators: United States Department of Defense
Conditions Hematologic Malignancies
Enrollment 190 participants
Start Date 2026-01-14
Primary Completion 2029-03-29 (estimated)
Study Completion 2029-03-29 (estimated)
Updated on ClinicalTrials.gov 2026-01-28